1. Sadykova LR, Ntekim AI, Muyangwa-Semenova M, Rutland CS, Jeyapalan JN, Blatt N, Rizvanov AA (2020) Epidemiology and risk factors of osteosarcoma. Cancer Invest 38(5):259–269. https://doi.org/10.1080/07357907.2020.1768401
2. Haas RL, Gronchi A, van de Sande MA, Baldini EH, Gelderblom H, Messiou C, Wardelmann E, Le Cesne A (2018) Perioperative management of extremity soft tissue sarcomas. J Clin Oncol 36(2):118–124
3. Franchi A (2012) Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab 9(2):92–95
4. Reed DR, Hayashi M, Wagner L, Binitie O, Steppan DA, Brohl AS, Shinohara ET, Bridge JA, Loeb DM, Borinstein SC (2017) Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer 123(12):2206–2218
5. Demetri GD, Baker LH, Beech D, Benjamin R, Casper ES, Conrad EU 3rd, DeLaney TF, Ettinger DS, Heslin MJ, Hutchinson RJ, Kiel K, Kraybill WG, Letson GD, Neff J, O’Donnell RJ, Paz IB, Pollock RE, Randall RL, Schupak KD, Tyler DS, von Mehren M, Wayne J (2005) Soft tissue sarcoma clinical practice guidelines in oncology. J Natl Compr Canc Netw 3(2):158–194